Clinical trials recruiting in Wuwei, China

Phase breakdown

Conditions recruiting in Wuwei, China

Recruiting trials in Wuwei, China

• A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer
  NCT07043725 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Clinical Study of Carbon Ion Radiotherapy for Pancreatic Cancer.
  NCT06840067 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female)
• Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease
  NCT06754891 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection (TQA2225/AP025) in Adult Subjects With Non-alcoholic Steatohepatitis (NASH)
  NCT06569524 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Evaluation of Fecal Multi-target Biomarkers in the Screening of Digestive Tract Cancers
  NCT07600125 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Wuwei, China?

5 recruiting trials have at least one study site in Wuwei, China.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.